Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chong Tan

Showing results (181-190 of 184) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 184 results.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.
Journal of the American Medical Informatics Association : JAMIA|July 14, 2023
Inferring cancer disease response from radiology reports using large language models with data augmentation and promptingRyan Shea Ying Cong Tan, Qian Lin, Guat Hwa Low, et al.
Pageof 19

Showing results (181-190 of 184) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 184 results.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2024
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLCStephanie P L Saw, Yi Fen Low, Gillianne G Y Lai, et al.
Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.
Journal of the American Medical Informatics Association : JAMIA|July 14, 2023
Inferring cancer disease response from radiology reports using large language models with data augmentation and promptingRyan Shea Ying Cong Tan, Qian Lin, Guat Hwa Low, et al.
Pageof 19